--- Query Results --- | |||
| Organization: | Alberta Precision Laboratories | ||
| Message Alert: | PLEASE NOTE: This Test Directory is in an interim state and due to changes pertaining to the DynaLIFE transition, performing site for routing has not been updated. Please refer to Laboratory Information System for appropriate routing. | ||
| Test Name/Synonym: | Patient Red Cell Genotype (Antigen, Geno) | ||
| Clinical Indications: | This test is used to: - Predict or confirm red cell phenotype in recently transfused patients and patients being treated with a drug that interferes with phenotyping (eg. daratumumab). - Assist with complex antibody investigation. - Distinguish alloantibody from autoantibody. - Confirm rare or unusual phenotypes. - Provide phenotypically matched blood. Not for Rh(D) genotyping. Refer to Patient RhD Genotyping. | ||
| Ordering Alert: | Note to ordering physician: This test will be reviewed for approval by Laboratory Medical or Scientific staff. | ||
| LABID (Connect Care): | LAB4322 | ||
| Test Code: | CALGARY ZONE: GENO CENTRAL ZONE, NORTH ZONE, SOUTH ZONE: LAB ORDERABLE ONLY | ||
| Specimen Type: | Blood | ||
| Specimen Source: | Venous | ||
| Primary Container: | EDTA Lavender | ||
| Minimum Collection Volume: | 4 mL *additional volume may be required if patient is leukopenic. | ||
| Method: | Polymerase Chain Reaction (PCR) | ||
| Method and Interpretation of Results: | Patients with red cell antibodies are generally expected to lack the corresponding antigen. Patients with red cell antibodies should be transfused with red blood cells negative for the corresponding antigen, where possible. | ||
| Testing Area: | Transfusion Medicine | ||
| Performing Site: | Referred to Canadian Blood Services | ||
| Last Updated On: | Tuesday, October 13, 2020 | ||
